Archive for 2007/12


Intensive Care Quality Of Sleep Improved By New Drug, Reports Study

A new sedative drug has been shown to improve the sleep quality and comfort levels of intensive care patients, compared to the most commonly-used medication, according to research published in the journal JAMA. [click link for full article]
(more...)


12/16/2007 | Respiratory & Asthma | Trackback | Comments Off

Molecular Pathway Appears Crucial In Development Of Pulmonary Fibrosis

A study led by Massachusetts General Hospital (MGH) researchers may have found a key mechanism underlying idiopathic pulmonary fibrosis (IPF), a usually fatal lung disease for which transplantation is the only successful treatment. The investigators found that a specific molecular pathway appears responsible for key aspects of the scarring of lung tissue that characterizes IPF, the cause of which is currently unknown. [click link for full article]
(more...)


12/16/2007 | Respiratory & Asthma | Trackback | Comments Off

What Science And History May Owe To Homeopathic Medicine

A new scholarly written book describes hundreds of well-known and respected physicians, scientists, politicians, corporate leaders, and literary greats who used or advocated for homeopathic medicine. Eleven U.S. Presidents, seven popes, Sir William Osler, J.D. Rockefeller, Charles Kettering, and C. Everett Koop are among those famous people who were known to have benefited from homeopathy. [click link for full article]
(more...)


12/15/2007 | Complememntary & Alternative Medicine | Trackback | Comments Off

Breathless Babies: Preemies’ Lung Function Shows Prolonged Impairment

Many premature babies face serious health challenges, not the least of which is breathing. But now research suggests that even relatively healthy preemies confront deficits in lung function that last into their second year, if not longer. "We have shown that healthy preterm infants have reduced lung function in the first months of life that persists into the second year of life," said principle investigator of the research, Marcus Herbert Jones, M.D., Ph.D. [click link for full article]
(more...)


12/14/2007 | Respiratory & Asthma | Trackback | Comments Off

Heavy Traffic Makes Breathing A Burden In Children

Exposure to traffic pollution may increase respiratory problems and reduce lung volumes in children with asthma, according to researchers who studied the effects of road and traffic density on children's lung function and respiratory symptoms in the border town of Ciudad Juarez in Mexico. [click link for full article]
(more...)


12/14/2007 | Respiratory & Asthma | Trackback | Comments Off

When Disease Discriminates: Women And COPD

Women have made a good deal of welcome progress in the last several decades, but at least one advance is unwanted: chronic obstructive pulmonary disease (COPD) is on the rise in women in prevalence, morbidity and mortality. By 2000, the number of women dying from COPD surpassed the number of men. But the rising number of cases in women has not been matched by medical understanding of the disease's apparent gender-bias. [click link for full article]
(more...)


12/14/2007 | Respiratory & Asthma | Trackback | Comments Off

Genzyme Study Of Myozyme(R) For Late-Onset Pompe Patients Meets Co Primary Efficacy Endpoints

Genzyme Corp. (Nasdaq: GENZ) announced that its Late Onset Treatment Study (LOTS) of Myozyme(R) (alglucosidase alfa) met its co-primary efficacy endpoints. The study was undertaken to evaluate the safety and efficacy of Myozyme in juvenile and adult patients with Pompe disease. Myozyme was first approved in 2006, and the product is now registered in 36 countries. [click link for full article]
(more...)


12/14/2007 | Respiratory & Asthma | Trackback | Comments Off

PARI’s EFlow Delivers Alnylam RNAi Therapeutic In Phase I Study

PARI's eFlow, an advanced electronic nebulizer, was optimized and used to deliver Alnylam's ALN-RSV01 in a Phase I human clinical trial. Results of the Phase I trial were announced at the 18th Annual Drug Delivery to the Lungs meeting held in Edinburgh, U.K. ALN-RSV01 is an RNAi therapeutic being developed as a treatment for respiratory syncytial virus (RSV) infection, the leading cause of pediatric hospitalization in the U.S. [click link for full article]
(more...)


12/14/2007 | Respiratory & Asthma | Trackback | Comments Off

Weill Cornell Receives $2.4 Million In Grants From Gates Foundation To Fight Tuberculosis

Weill Cornell Medical College has received two grants totaling $2.4 million from the Bill & Melinda Gates Foundation to help fight tuberculosis, an epidemic that infects one-third of the world's people and kills nearly two million yearly -- mostly in the poorest countries.The grants will support research towards developing innovative TB drugs that are more effective than current treatment options. [click link for full article]
(more...)


12/13/2007 | Respiratory & Asthma | Trackback | Comments Off

Coughing: A Sign Of A Serious Condition?

Do you or your child wake up coughing, or have a prolonged cough lasting for weeks? Parents should recognize that this is something potentially serious requiring medical attention, according to the American Academy of Allergy, Asthma & Immunology (AAAAI). "Cough is the most common respiratory symptom for which patients seek medical attention," said Alan B. Goldsobel, MD, FAAAAI, and Chair of the AAAAI's Cough Committee. [click link for full article]
(more...)


12/12/2007 | Respiratory & Asthma | Trackback | Comments Off

« Previous Entries
Next Entries »

© 2006 MBGJ.Org Limited Trading as Natural-Remedies-Clinic

All rights reserved - Designated trademarks and brands are the property of their respective owners

Natural Remedies Clinic - Main Site


Page Sponsors

- -

>-- Top of Page --<